Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2002
03/19/2002US6358711 Generating polyclonal antibody; immunize animal, isolate animal antibodies, screen isolated antibodies with the polypeptide and detect binding of polyclonal antibody
03/19/2002US6358710 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13
03/19/2002US6358707 Polynucleotide sequences coding polypeptide associated with cellular secretion; for use in treatment of diabetes, stroke, atherosclerosis, restenosis, thrombosis, autoimmune disease, psoriasis, arthritis, crohn's, and inflammatory defects
03/19/2002US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis
03/19/2002US6358704 M protein
03/19/2002US6358703 Expression system for factor VIII
03/19/2002US6358702 Polynucleotides encoding human Hox C10
03/19/2002US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide
03/19/2002US6358694 Culturing prostaglandin receptor expressing cells in the presence of a test compound; measure the modulating affects of the compound that interacts with the recombinant receptor and compare the affects with a control host cell
03/19/2002US6358693 AMPA-binding human gluR4 receptor methods
03/19/2002US6358689 Detection of markers in nascent proteins
03/19/2002US6358534 For therapy of hemophilia
03/19/2002US6358530 Powdered pharmaceutical formulations having improved dispersibility
03/19/2002US6358524 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use
03/19/2002US6358514 Combination of a retinoid with a histidine derivative
03/19/2002US6358513 Local administration of a therapeutically effective amount of a botulinum toxin to a patient, thereby increasing secretion of thyroid hormone, and ameliorating severity of hashimoto's thyroiditis for between two months to six months
03/19/2002US6358511 Inhibitors of HIV infection
03/19/2002US6358510 ICAM-1 derivatives with altered ability to bind LFA-1
03/19/2002US6358509 Administering to animal a polypeptide wherein animal produces antibodies against polypeptide, antibodies being able to specifically bind to human il-4 and are able to inhibit binding of human il-4 to cellular receptors
03/19/2002US6358508 Antibodies to human tumor necrosis factor receptor TR9
03/19/2002US6358507 Transgene expression systems
03/19/2002US6358504 Compounds and compositions for delivering active agents
03/19/2002US6358491 Somatostatin analogs
03/19/2002US6358443 Directing microdroplets into freezing section containing a liquefied gas; contacting frozen microdroplets in extraction section with liquid non-solvent to extract solvent into non-solvent to form microparticles
03/19/2002US6358234 Absorbent article having deformed hinge and zones of extensibility
03/19/2002US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures
03/19/2002CA2231886C Copolymeric micelle drug composition and method for the preparation thereof
03/19/2002CA2193384C Use of gabapentin in the treatment of anxiety and panic
03/19/2002CA2131316C A thrombin blood fraction for use in a medical procedure
03/19/2002CA2128078C Nutritional product for trauma and surgery patients
03/19/2002CA2099779C Mixed specificity fusion proteins
03/19/2002CA2032303C Inhibitors of retroviral proteases
03/19/2002CA2008390C Mutants of human antithrombin iii
03/19/2002CA2007075C New thrombolytic compositions
03/19/2002CA1341348C Human tumor necrosis factor
03/17/2002WO2002017957A1 Solution preparations stabilized over long time
03/15/2002CA2357074A1 Novel bcl-2 related proline rich protein (bpr)
03/14/2002WO2002021141A2 Methods and compositions for diseases associated with amyloidosis
03/14/2002WO2002021140A1 Nucleic acid sequences and proteins involved in cellular senescence
03/14/2002WO2002020840A1 Antisense modulation of ubiquitin protein ligase expression
03/14/2002WO2002020830A2 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds
03/14/2002WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
03/14/2002WO2002020813A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
03/14/2002WO2002020809A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin
03/14/2002WO2002020807A1 L-methionine $g(g)-lyase with modified function
03/14/2002WO2002020805A2 Regulation of human carboxypeptidase-like enzyme
03/14/2002WO2002020802A1 A cell line expressing mutant human tissue-type plasminogen activator, constructing strategy and method of expressed protein preparation
03/14/2002WO2002020801A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
03/14/2002WO2002020798A1 A novel polypeptide- human dehydrogenase 56 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020795A1 A novel polypeptide- hexokinase protein 9.68 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020790A1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them
03/14/2002WO2002020789A1 Gcn4-derived expression of heterologous coding sequences
03/14/2002WO2002020788A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020785A1 Novel polypeptide---a human parkinson's disease related protein 11 and polynucleotide encoding it
03/14/2002WO2002020784A1 Novel polypeptide--- a ribosomal protein s1111.22 and polynucleotide encoding it
03/14/2002WO2002020781A1 A novel polypeptide- marrow transposition gene related protein 12.32 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020778A1 A novel polypeptide-human calcitonin 15.18 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020777A1 A NOVEL POLYPEPTIDE- CELL SIGNAL TRANSDUCER PROTEIN MyD24.09 AND THE POLYNUCLEOTIDE ENCODING SAID POLYPEPTIDE
03/14/2002WO2002020776A1 A novel polypeptide-mgc-2413.31 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020775A1 A novel polypeptide- cyclin-dependent kinase-cdk411 and the polynucleotide encoding said polypeptide
03/14/2002WO2002020769A1 Human and mouse targeting peptides identified by phage display
03/14/2002WO2002020768A2 Caveolin peptides and their use as therapeutics
03/14/2002WO2002020767A2 G-csf analog compositions and methods
03/14/2002WO2002020766A2 G-csf analog compositions and methods
03/14/2002WO2002020765A2 38646, a guanine nucleotide exchange factor and uses therefor
03/14/2002WO2002020763A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020762A2 Tnf receptor-like molecules and uses thereof
03/14/2002WO2002020757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/14/2002WO2002020756A2 Secretory molecules
03/14/2002WO2002020754A2 Molecules for diagnostics and therapeutics
03/14/2002WO2002020751A2 Hyperglycosylated polypeptides
03/14/2002WO2002020744A1 Novel polypeptide--- a human endo type protease 23.32 and polynucleotide encoding it
03/14/2002WO2002020743A1 A new polypeptide- human i kappa b kinase 15 and the polynucleotide encoding it
03/14/2002WO2002020742A1 Use of ip3 kinases for preparing medicines for treating oxidative stress-related diseases
03/14/2002WO2002020736A2 Proteases
03/14/2002WO2002020732A2 Regulation of human map kinase phosphatase-like enzyme
03/14/2002WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
03/14/2002WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo
03/14/2002WO2002020722A2 Methods and compositions for in vitro targeting
03/14/2002WO2002020718A2 Osteoclast-associated receptor
03/14/2002WO2002020716A2 Antisense modulation of phosphorylase kinase alpha 2 expression
03/14/2002WO2002020715A2 Peptide conjugated anti-cancer prodrugs
03/14/2002WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3)
03/14/2002WO2002020617A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma
03/14/2002WO2002020615A2 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders
03/14/2002WO2002020610A2 Conformationally constrained labeled peptides for imaging and therapy
03/14/2002WO2002020609A2 Interleukin-11 for the treatment of stroke and neuropathies
03/14/2002WO2002020608A1 A new polypeptide- human lymph enhanced factor 42 and the polynucleotide encoding it
03/14/2002WO2002020607A1 A NEW POLYPEPTIDE-HUMAN BIPHENYL HYDROLASE-RELATED PROTEIN (Bph-rp)16.06 AND THE POLYNUCLEOTIDE ENCODING IT
03/14/2002WO2002020606A1 A new polypeptide- human hearing defect-related protein 38.39 and the polynucleotde encoding it
03/14/2002WO2002020605A1 A NEW POLYPEPTIDE-HUMAN CELL CYCLIN-E BINDING PROTEIN 1(Ceb1)113-70.07 AND THE POLYNUCLEOTIDE ENCODING IT
03/14/2002WO2002020604A1 A new polypeptide- human double-stranded rna binding protein 11 and the polynucleotide encoding it
03/14/2002WO2002020603A1 A new polypeptide- human tropomodulin 25.08 and the polynucleotide encoding it
03/14/2002WO2002020602A1 A novel peptide---human short chain dehydrogenase 9.9 and the polynucleotide coding this novel peptide
03/14/2002WO2002020601A1 A novel peptide---human cartilage connective protein 10.67 and the polynucleotide coding this novel peptide
03/14/2002WO2002020600A1 A new polypeptide- human zinc finger protein 10.45 and the polynucleotide encoding it
03/14/2002WO2002020599A1 A new polypeptide- human transcription regulation factor zfm1 isomer 19.47 and the polynucleotide encoding it
03/14/2002WO2002020598A1 Mucin
03/14/2002WO2002020597A2 Human vomeronasal receptor-5
03/14/2002WO2002020596A2 Maurotoxin, pi1 and hstx1 derivatives
1 ... 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 ... 3163